News | News By Subject | News by Disease News By Date | Search News

Anemia, sickle cell News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Global Blood Therapeutics (GBT) Stock Surges on Promising Sickle Cell Drug Results     6/10/2016
bluebird bio (BLUE) Gets Banged Up on Report of Gene Therapy Patient Needing Blood Transfusions     10/21/2015
Novartis AG (NVS) Takes Another 2.5% Stake in Gamida Cell     10/12/2015
bluebird bio (BLUE) Surges as Pioneering Sickle Cell Gene Therapy Working for 13-Year-Old French Boy     6/18/2015
Stock Soars as bluebird bio (BLUE) Gives Sneak Peek at Promising Sickle Cell Data     5/26/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
J.P. Morgan: bluebird bio (BLUE) Soars On CEO's Sickle Cell Data     1/16/2015
bluebird bio (BLUE)’s New Blood Treatment Could Benefit Sickle Cell, Says Analyst     12/9/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
LentiGlobin Looks Promising On Sickle Cell For bluebird bio (BLUE), Says Analyst     11/19/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Cellerant Therapeutics, Inc. Raises $16 Million To Advance Stem Cell-Based Therapies For Life-Threatening Diseases; Series B proceeds To Fund Cancer, Sickle Cell And Autoimmune Programs     5/11/2005
National Institutes of Health (NIH) Issues Alert; Federal Health Agency Halts Sickle Cell Study Because Subjects Suffer Strokes     12/6/2004
Icagen, Inc. Receives Milestone Payment From McNeil Consumer & Specialty Pharmaceuticals (JNJ)     9/2/2004

News from Around the Web
Why 2017 Will be a Data-Rich and Not Revenue-Focused Year for bluebird bio (BLUE)     2/24/2017
Stanford University Researchers Use CRISPR to Repair Gene That Cause Sickle Cell, Human Trials Planned     11/8/2016
An Easy Test for Sickle Cell Disease, University of Connecticut Study     11/5/2015
Stem Cell Transplant Stops Sickle Cell In Potential Cure, National Institutes of Health (NIH) Reveals     7/2/2014
Malaria May Be Eliminated From a Quarter of Nations in 10 Years, Roll Back Malaria Partnership Reveals     10/18/2011
Fetal Hemoglobin Production Reverses Sickle Cell Anemia, Dana-Farber Cancer Institute Study     10/14/2011
Common Drug Helps Babies with Sickle Cell Disease, St. Jude Children's Research Hospital Study Finds     5/13/2011
American Society of Hematology: Compound Cuts Death Risk for Sickle Cell Kids     12/6/2010
Inhaling Nitric Oxide Eases Pain Crises in Sickle Cell Patients, Medical College of Georgia Researchers Find     10/20/2010
National Heart, Lung, and Blood Institute Stops Study of Treatment for Pulmonary Hypertension in Patients with Sickle Cell Disease Due to Safety Concerns     7/28/2009
Gene May Open Door For New Sickle Cell Therapies, Harvard Medical School Study     12/5/2008
Researchers At Johns Hopkins University Develop Stem Line With Sickle Cell Mutation     5/30/2008
Scientists Cure Mice With Sickle Cell     12/7/2007
Anticancer Drugs Might be of Benefit to Sickle-Cell Patients     12/7/2007
Blood Test Predicts Sickle Cell Disease Complication, Identifies Patients At High Risk Of Death     7/19/2006

Press Releases
Emmaus Life Sciences Announces FDA Advisory Committee Meeting For Endari For Sickle Cell Disease     4/18/2017
AllCells Selected By Children’s Hospital Oakland Research Institute (CHORI) To Perform Blood Processing Of SCD Patients Under CIRM Translational Award Program     3/23/2017
bluebird bio (BLUE) Announces Publication Of Case Study On First Patient With Severe Sickle Cell Disease Treated With Gene Therapy In The New England Journal of Medicine     3/2/2017
Modus Raises SEK 32 Million To Support Development Of Sevuparin For Sickle Cell Disease     2/20/2017
Global Blood Therapeutics (GBT) Announces Publication Of Paper Describing Discovery Of GBT440 In American Chemical Society Medicinal Chemistry Letters     2/14/2017
bluebird bio (BLUE) Announces First Patient Treated With Lentiglobintm Drug Product Under Amended Study Protocol In HGB-206 Phase I Study Of Patients With Severe Sickle Cell Disease     2/3/2017
Imara Receives Orphan Drug Designation For Lead Product Candidate IMR-687 For Sickle Cell Disease     2/2/2017
Exemplar Genetics Release: Company Awarded Subcontract To Advance New Therapeutic Models For Sickle Cell Disease     1/26/2017
Global Blood Therapeutics (GBT) Release: Company Announces Enrollment Of First Patient In Phase III HOPE Study In Sickle Cell Disease     1/18/2017
SPCI Launched The SCOT (Sickle Cell Omega-3 Treatment) Trial N The United States With An Investigator Meeting Held December 16-17 In Atlanta     12/19/2016
Emmaus Life Sciences Receives Japanese Patent For Use Of L-Glutamine In Treatment Of Diverticulosis     12/13/2016
Global Blood Therapeutics (GBT) Announces New Details On Its Novel Patient Reported Outcomes (PRO) Tool To Be Used In Phase III HOPE Study     12/6/2016
Gamida Cell Presents Positive Data From Phase 1/2 Study Of NiCord as A Curative Treatment For Sickle Cell Disease At American Society of Hematology 2016     12/6/2016
Novartis AG (NVS) SEG101 (Crizanlizumab, formerly SelG1) Significantly Reduces Frequency Of Sickle Cell Pain Crises In Phase II Study     12/5/2016
Global Blood Therapeutics (GBT) Announces New Long-Term Clinical Data From Ongoing Phase I/II Trial Of GBT440 In Sickle Cell Disease At American Society of Hematology     12/5/2016